ReviewCancers2022
Timeline of FDA-Approved Targeted Therapy for Cholangiocarcinoma.
Su Min Cho et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papercites it
ReviewCancers2022
Su Min Cho et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.